187 related articles for article (PubMed ID: 23506956)
21. Development of a gastroretentive pulsatile drug delivery platform.
Thitinan S; McConville JT
J Pharm Pharmacol; 2012 Apr; 64(4):505-16. PubMed ID: 22420657
[TBL] [Abstract][Full Text] [Related]
22. Stability of aqueous polymeric controlled release film coatings.
Siepmann J; Siepmann F
Int J Pharm; 2013 Dec; 457(2):437-45. PubMed ID: 24126037
[TBL] [Abstract][Full Text] [Related]
23. Site specific chronotherapeutic drug delivery systems: a patent review.
Saigal N; Baboota S; Ahuja A; Ali J
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):64-70. PubMed ID: 19149730
[TBL] [Abstract][Full Text] [Related]
24. Distinctive features of "chronotherapeutic" and "pulsatile" drug delivery systems negating the practice of their interchangeable terminology.
Ali J; Baboota S; Ahuja A; Saigal N
J Drug Target; 2010 Jul; 18(6):413-9. PubMed ID: 20132094
[TBL] [Abstract][Full Text] [Related]
25. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
26. Chronopharmaceutics: as a clinically relevant drug delivery system.
Gandhi BR; Mundada AS; Gandhi PP
Drug Deliv; 2011 Jan; 18(1):1-18. PubMed ID: 21138394
[TBL] [Abstract][Full Text] [Related]
27. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques.
Genina N; Fors D; Vakili H; Ihalainen P; Pohjala L; Ehlers H; Kassamakov I; Haeggström E; Vuorela P; Peltonen J; Sandler N
Eur J Pharm Sci; 2012 Oct; 47(3):615-23. PubMed ID: 22902482
[TBL] [Abstract][Full Text] [Related]
28. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
29. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
Kadam VD; Gattani SG
Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
[TBL] [Abstract][Full Text] [Related]
30. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives.
Roy P; Shahiwala A
J Control Release; 2009 Mar; 134(2):74-80. PubMed ID: 19105973
[TBL] [Abstract][Full Text] [Related]
31. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
[TBL] [Abstract][Full Text] [Related]
32. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
Kadam VD; Gattani SG
Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
[TBL] [Abstract][Full Text] [Related]
33. Injection Molding and its application to drug delivery.
Zema L; Loreti G; Melocchi A; Maroni A; Gazzaniga A
J Control Release; 2012 May; 159(3):324-31. PubMed ID: 22245483
[TBL] [Abstract][Full Text] [Related]
34. Extrudable core system: development of a single-layer osmotic controlled-release tablet.
Waterman KC; MacDonald BC; Roy MC
J Control Release; 2009 Mar; 134(3):201-6. PubMed ID: 19100796
[TBL] [Abstract][Full Text] [Related]
35. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
36. Pharmaceutically used polymers: principles, structures, and applications of pharmaceutical delivery systems.
Khandare J; Haag R
Handb Exp Pharmacol; 2010; (197):221-50. PubMed ID: 20217532
[TBL] [Abstract][Full Text] [Related]
37. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176
[TBL] [Abstract][Full Text] [Related]
38. Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review.
Pandit V; Kumar A; Ashawat MS; Verma CP; Kumar P
Curr Drug Targets; 2017; 18(10):1191-1203. PubMed ID: 26853323
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of powder-layering vs. spray-coating techniques in the manufacturing of a swellable/erodible pulsatile delivery system.
Foppoli A; Cerea M; Palugan L; Zema L; Melocchi A; Maroni A; Gazzaniga A
Drug Dev Ind Pharm; 2020 Aug; 46(8):1230-1237. PubMed ID: 32597251
[TBL] [Abstract][Full Text] [Related]
40. Use of scoring to induce reproducible drug delivery from osmotic pulsatile tablets.
Rahemba TR; Bell S; Connolly EK; Waterman KC
Pharm Dev Technol; 2009; 14(5):548-55. PubMed ID: 19552560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
